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Several cytokines and chemokines are now known to play normal physiological roles in
the brain where they act as key regulators of communication between neurons, glia, and
microglia. In particular, cytokines and chemokines can affect cardinal cellular and molecular
processes of hippocampal-dependent long-term memory consolidation including synaptic
plasticity, synaptic scaling and neurogenesis. The chemokine, CX3CL1 (fractalkine), has
been shown to modulate synaptic transmission and long-term potentiation (LTP) in the
CA1 pyramidal cell layer of the hippocampus. Here, we conﬁrm widespread expression of
CX3CL1 on mature neurons in the adult rat hippocampus. We report an up-regulation in
CX3CL1 protein expression in the CA1, CA3 and dentate gyrus (DG) of the rat hippocampus
2 h after spatial learning in the water maze task. Moreover, the same temporal increase
in CX3CL1 was evident following LTP-inducing theta-burst stimulation in the DG. At
physiologically relevant concentrations, CX3CL1 inhibited LTP maintenance in the DG.This
attenuation in dentate LTP was lost in the presence of GABAA receptor/chloride channel
antagonism. CX3CL1 also had opposing actions on glutamate-mediated rise in intracellular
calcium in hippocampal organotypic slice cultures in the presence and absence of GABAA
receptor/chloride channel blockade. Using primary dissociated hippocampal cultures, we
established that CX3CL1 reduces glutamate-mediated intracellular calcium rises in both
neurons and glia in a dose dependent manner. In conclusion, CX3CL1 is up-regulated in
the hippocampus during a brief temporal window following spatial learning the purpose of
which may be to regulate glutamate-mediated neurotransmission tone. Our data supports
a possible role for this chemokine in the protective plasticity process of synaptic scaling.
Keywords: calcium imaging, chemokine signaling, fractalkine, learning and memory, LTP, water maze
INTRODUCTION
While higher inﬂammatory and pathophysiological levels of
cytokines are implicated in a range of neuropsychiatric and
neurodegeneration diseases, it is now equally evident that,
within the central nervous system (CNS), cytokines, includ-
ing the chemoattractant cytokines (chemokines), mediate
physiological signaling functions far beyond and indepen-
dent of their traditional roles in inﬂammation and dis-
ease (Hopkins and Rothwell, 1995; Rothwell and Hopkins, 1995;
Reichenberg et al., 2001; Pollmächer et al., 2002;Wilson et al., 2002;
Adler and Rogers, 2005; Adler et al., 2006; McAfoose and Baune,
2009; Hoshiko et al., 2012; Williamson and Bilbo, 2013). In par-
ticular, pro-inﬂammatory cytokines such as interleukin (IL)-1,
IL-6, and tumor necrosis factor alpha (TNF-α) have all been
implicated in cardinal cellular and molecular processes of long-
term hippocampal-dependent memory consolidation including
synaptic plasticity, synaptic scaling and neurogenesis (Malenka
and Bear, 2004; Bruel-Jungerman et al., 2007a,b; Turrigiano, 2007;
Baier et al., 2009; McAfoose and Baune, 2009; Bachstetter et al.,
2011; Ben Menachem-Zidon et al., 2011; Yirmiya and Goshen,
2011; del Rey et al., 2013; Gemma and Bachstetter, 2013). For
example, at physiological levels, IL-1 promotes long-term poten-
tiation (LTP), a widely employed electrophysiological model of
memory-associated synaptic plasticity, whereas IL-6 appears to
exert inhibitory inﬂuences on excessive excitation during LTP
maintenance (Li et al., 1997; Coogan et al., 1999; Ross et al., 2003;
Balschun et al., 2004). Interestingly, production of both IL-1 and
IL-6 is increased following LTP induction, further supporting a
role for cytokines inmodulatingmemory-associated synaptic plas-
ticity and network-protective synaptic scaling (Schneider et al.,
1998; Jankowsky et al., 2000). Our aim in the current study was
to assess the effects of the chemokine, CX3CL1, also known as
neurotactin or fractalkine, on hippocampal-dependent synaptic
plasticity processes such as spatial memory and LTP. CX3CL1
is highly expressed on hippocampal neurons in the post-natal
and adult rat and declines in old age which has been linked to
cognitive decline in rodents (Lyons et al., 2009). In this study,
we investigated if CX3CL1 plays a normal physiological role in
hippocampal-dependent synaptic plasticity.
Several chemokines are widely expressed throughout the CNS
during development and throughout life where they have been
shown to play diverse roles in cell migration and differentiation
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(Lu et al., 2002), regulation of cellular communication in the adult
brain (Tran and Miller, 2003) and neuroprotection (Araujo and
Cotman, 1993; Meucci et al., 1998; Robinson et al., 1998; Bruno
et al., 2000; Limatola et al., 2000; Hatori et al., 2002; Deiva et al.,
2004; Krathwohl and Kaiser, 2004; Limatola et al., 2005; Catalano
et al., 2013; Shepherd et al., 2013). CX3CL1 is the only member
of the chemokine δ subfamily (Rostene et al., 2007). Most other
chemokines bind several G protein-coupled receptors to mediate
their activities and so CX3CL1 is unusual in that it appears to
bind only one receptor, the Gi protein-coupled receptor, CX3CR1
(Allen et al., 2007). The full-length molecule is also larger than
most other chemokines, containing approximately 373 amino
acid residues compared to the more common 70–80 amino acid
size. The 95 kDa full-length protein is a type I transmembrane
protein consisting of a 76-amino acid N-terminal chemokine
domain, a 241-amino acid glycosylated mucin-like stalk, an
18-amino acid transmembrane region and an intracellular C-
terminal domain. The approximately 70 kDa soluble N-terminal
chemokine domain can be released from the full-length protein
via the action of several metalloproteinases such as cathepsin S,
ADAM10, and ADAM17 (TACE: TNF-α-converting enzyme) in
both the periphery and CNS (Garton et al., 2001; Hundhausen
et al., 2003; Clark et al., 2007; Cook et al., 2010; Jones et al., 2013).
Unlike most chemokines, CX3CL1 is constitutively expressed in
the CNS with particularly high levels in hippocampal neurons
(Harrison et al., 1998). CX3CR1, the only known receptor for
CX3CL1, is expressed predominantly on microglia in the mouse
CNS (Cardona et al., 2006). The cell type expression pattern of
CX3CR1 in the CNS remains controversial, however, since several
studies report CX3CR1 expression on neurons in vitro as well as in
brain regions including the hippocampus, Raphe nucleus, nucleus
of the solitary tract (NTS) and paraventricular nucleus (PVN) of
the hypothalamus in rats (Meucci et al., 1998, 2000; Maciejewski-
Lenoir et al., 1999; Hatori et al., 2002; Hughes et al., 2002; Tarozzo
et al., 2003; Verge et al., 2004; Limatola et al., 2005; Zhuang et al.,
2007; Heinisch and Kirby, 2009; Ruchaya et al., 2012, 2014).
The high basal level of CX3CL1 mRNA and protein expres-
sion in the hippocampus is suggestive of a physiological, non-
inﬂammatory function. Indeed, there is mounting evidence which
implicates both CX3CL1 and its receptor, CX3CR1, in synaptic
plasticity and neuromodulation (Bertollini et al., 2006; Ragozzino
et al., 2006; Piccinin et al., 2010; Maggi et al., 2011; Rogers et al.,
2011; Roseti et al., 2013; Scianni et al., 2013). For example,CX3CL1
has been shown to reduce spontaneous glutamate release and
post-synaptic glutamate currents (Meucci et al., 1998; Limatola
et al., 2005). The latter effect has been linked to increased intra-
cellular calcium and dephosphorylation of the GluR1 AMPA
receptor subunit (Ragozzino et al., 2006). These synaptic effects
are consistent with a direct action of CX3CL1 on neurons most
likely exerted through the CX3CR1 receptor, which is reportedly
expressed on the dendrites of hippocampal neurons (Meucci et al.,
2000; Limatola et al., 2005). Overall, previous studies indicate a
predominantly inhibitory role for CX3CL1, perhaps as a compo-
nent of neuroprotective synaptic scaling mechanisms necessary
for hippocampal memory-associated synaptic plasticity processes
(Bertollini et al., 2006; Turrigiano, 2008; Piccinin et al., 2010).
Consistent with this hypothesis, ADAM17-mediated increase in
soluble CX3CL1 is observed in multiple settings of glutamatergic
neurotransmission where the chemokine is suggested to perform a
neuroprotective function (Chapman et al., 2000; Tsou et al., 2001;
Erichsen et al., 2003; Limatola et al., 2005; Ragozzino et al., 2006;
Lauro et al., 2010; Pabon et al., 2011). At levels reached during
inﬂammatory conditions, CX3CL1 signaling has previously been
associatedwith activation of pro-survival and anti-apoptotic path-
ways through phosphorylation of molecules such as Akt, as well
as activation of MAP kinases such as p-38 and Erk1/2 (p44/42;
Maciejewski-Lenoir et al., 1999; Meucci et al., 2000; Cambien
et al., 2001; Deiva et al., 2004; Klosowska et al., 2009; Lyons et al.,
2009).
In the present study, we investigated if CX3CL1 expression is
actively regulated in the hippocampus during a normal spatial
learning event and also after the induction of LTP. We demon-
strate the ability of physiological levels of CX3CL1 to inhibit the
maintenance of LTP and the importance of dentate gyrus (DG)
GABAergic neurotransmission to facilitating this attenuation of
hippocampal synaptic plasticity. Finally, we provide evidence that
the effects of CX3CL1 on synaptic plasticity may relate to sup-
pression of glutamate-mediated calcium inﬂux, particularly in
hippocampal neurons.
MATERIALS AND METHODS
ANIMAL MAINTENANCE AND BEHAVIORAL ASSESSMENT
Postnatal day 80maleWistar rats (330–380 g) were used for behav-
ioral studies and were obtained from the Biomedical Facility at
University College Dublin, Ireland. All experimental procedures
were approved by the Animal Research Ethics Committee of the
Biomedical Facility at UCD and were carried out by individuals
who held the appropriate license issued by the Minister for Health
and Children. Animals were housed in groups of four and given ad
libitum access to food and water. The experimental room was kept
on a 12 h light/dark cycle at 22 ± 2◦C. The behavior of each animal
was assessed in an open ﬁeld apparatus (620 mm long, 620 mm
wide, and 150mmhigh) both 48 and 24 h prior to commencement
of training. The base of the open ﬁeld box was demarcated into
an 8 × 8 grid. The animals’ locomotion, rearing, and grooming
behavior was monitored over a 5 min period and deemed normal
prior to water maze training (data not shown). Their weights were
also recorded immediately following the open ﬁeld. Behavioral
assessment was conducted in a quiet room under low-level red
light illumination.
WATER MAZE TRAINING
On postnatal day 80, animals were trained in the Morris water
maze spatial learning task. Brieﬂy, the water maze apparatus con-
sists of a large circular pool (150 cm diameter, 80 cm deep) and
a hidden platform (11 cm diameter). Both were constructed from
black polyvinyl plastic, offering no intramaze visual cues that may
help guide escape behavior. The platform was submerged 1.5 cm
below the water surface (temperature 26 ± 1◦C) and positioned
30 cm from the edge of the maze wall. The platform remained
in the same position throughout the training session. The exper-
imental room contained several extra-maze visual cues. The rat
was lowered into the water facing the wall of the maze (30 cm
high) at one of three locations which were alternated with each
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trial. Trials lasted a maximum of 90 s and the length of time taken
for the rat to ﬁnd the hidden platform was recorded. Rats failing
to ﬁnd the platform within the 90 s were placed on it for 10 s
and allowed orient themselves. The training session consisted of
ﬁve trials with an inter-trial interval of 300 s. Each trained animal
was assigned a corresponding passive control animal that spent
the same lengths of time swimming in the pool, minus the plat-
form. After training, the rats were dried-off and placed back into
their home cages. They were then killed by cervical dislocation
at speciﬁc time-points post-training, i.e. 1, 2, or 3 h after com-
mencement of the third trial. Brains used for immunoﬂuorescent
labeling procedures were quickly dissected out, covered in optimal
cutting temperature (OCT compound; Agar Scientiﬁc) and snap
frozen in N-hexane cooled to –80◦C with CO2.
IMMUNOFLUORESCENT LABELING OF HIPPOCAMPAL CX3CL1
Coronal cryosections of whole brain were taken at –3.3 mm with
respect to Bregma in order to examine the dorsal hippocampus
(Paxinos and Watson, 2005). The 12 μm sections were adhered
to glass slides coated with poly-L-lysine. Sections were ﬁxed in
70% ethanol for 25 min and then washed in phosphate-buffered
saline (PBS). Sections were then incubated for 18 h at room tem-
perature in primary antibody solution. The primary antibodies
used were: (1) AF537 (R&D Systems; 1:250 dilution), a goat IgG
polyclonal antibody that labels recombinant rat CX3CL1 and; (2)
MAB377 (Millipore; 1:500 dilution), a mouse IgG monoclonal
antibody that detects the neuronal marker NeuN. The primary
antibody solution consisted of 1% bovine serum albumin (BSA)
and 1%normal rabbit serum in PBS. Following two 10minwashes
in PBS, sections were incubated for 3 h with a rabbit anti-goat
IgG secondary antibody conjugated to FITC (Sigma; 1:1000 dilu-
tion) which detected the CX3CL1 antibody. The NeuN primary
antibody was detected by a rabbit anti-mouse IgG TRITC-labeled
secondary antibody (Sigma; 1:1000 dilution). Where applicable,
nuclei were visualized using either propidium iodide or Hoechst
33258 (Invitrogen). Sections were mounted in Citiﬂuor glycerol
PBS solution (Agar Scientiﬁc), cover-slipped and stored in dark-
ness at 4◦C until imaged. To minimize any potential confounder
effects from the immunohistochemical technique, trained sections
were prepared, stained and imaged at the same time as their
relevant passive control.
ACUTE HIPPOCAMPAL SLICE PREPARATION AND fEPSP RECORDING
Post-natal day 21–25 male Wistar rats (60–100 g) were obtained
from the Biomedical Facility, University College Dublin, Ire-
land. All experimental procedures were approved by the Animal
Research Ethics Committee of the Biomedical Facility at UCD.
Animals were anesthetized using isoﬂurane (Abbott Laboratories
Ireland Ltd.) and decapitated by guillotine. The brain was rapidly
removed and placed into ice-cold artiﬁcial cerebro-spinal ﬂuid
(aCSF) bubbled with 95% O2 and 5% CO2 (aCSF composition:
120 mM NaCl, 26 mM NaHCO3, 1.25 mM NaH2PO4, 2.5 mM
KCl, 2 mM MgSO4·7H20, 2 mM CaCl2 and 10 mM D-glucose).
This high magnesium aCSF facilitates slice viability and recovery
through greater NMDA receptor blockade. Transverse hippocam-
pal slices (400 μm) were cut from both hemispheres using a
vibroslice (Campden Instruments). They were then transferred
to a submerged incubation chamber containing bubbled, room
temperature aCSF and allowed to recover for 90 min. Following
this recovery period, sliceswere transferred to a recording chamber
perfusedwith aCSF at a ﬂow rate of 4–5ml/min at 31 ± 0.5◦C. The
composition of aCSF used for recording was a modiﬁed version
of that used during slice recovery, i.e., the MgSO4·7H2O con-
tent was reduced to 1.3 mM to decrease NMDA receptor blockade
and facilitate LTP induction. Extracellular ﬁeld excitatory post-
synaptic potentials (fEPSPs) were elicited by stimulation of the
medial perforant path of the DG by a monopolar glass electrode
at a frequency of 0.05 Hz. Responses were recorded using a glass
electrode placed in the middle third of the molecular layer and
stimulus strength was adjusted to give a response 35% of maximal.
The effect of 500 pM rCX3CL1 (recombinant rat CX3CL1, Pepro-
tech EC) on LTP in the DG was investigated both in the presence
and absence of 100 μM of the GABAA receptor/chloride channel
inhibitor, picrotoxin (Sigma–Aldrich). Stable baseline recordings
were made for at least 20 min prior to application of drugs. LTP
was induced by theta-burst stimulation (TBS) consisting of eight
trains (40 ms duration) of eight pulses at 200 Hz with 2 s intervals
between trains and at a stimulus strength corresponding to 70%
of maximal. Following TBS, the stimulus voltage was returned to
that of baseline levels and fEPSPs were recorded every 20 s for a
further 60 min.
FREEZING OF HIPPOCAMPAL SLICES FOR IMMUNOSTAINING
Slices were coated in OCT (Agar UK) and snap-frozen in n-hexane
cooled to –80◦C with compressed CO2. Hippocampal slices were
cryosectioned into 12 μmsections that were adhered to glass slides
and immunoﬂuorescently stained for CX3CL1 (as above). Nuclei
were counterstained with propidium iodide.
PREPARATION OF ORGANOTYPIC HIPPOCAMPAL SLICE CULTURES
Organotypic hippocampal cultures were prepared according to
Stoppini et al. (1991). Brieﬂy, post-natal day 7 male Wistar rats
were decapitated without anaesthetic and their brains quickly
dissected out and placed into ice-cold Earle’s balanced salt solu-
tion (EBSS) for 1 min. Both hippocampi were removed and
cut into 400 μm slices using a McIlwain tissue chopper. Slices
were separated and arranged onto organotypic inserts (three per
insert, Millicell PICMORG50). The inserts were housed in stan-
dard six-well cell culture plates which were kept in an incubator
at 35◦C and 5% CO2 in air. The slices were grown using an
interface method with 1 ml organotypic medium supplying the
under-surface of the slice. The organotypic medium consisted
of 50% minimum essential medium (MEM, Gibco), 25% EBSS
(Gibco), 25% heat-inactivated horse serum (Sigma) and sup-
plemented with 2 mM glutamine, 28 mM D-glucose, 100 U/ml
penicillin/streptomycin, and 25 mM HEPES. The ﬁrst medium
change was conducted 24 h following slice preparation with sub-
sequent medium changes occurring every 2 days. Slices were
maintained for 21 days in vitro (DIV) prior to experimentation.
CONFOCAL MICROSCOPY
All confocal images used for quantitative analysis of immunoﬂu-
orescence (12-bit; 1024 × 1024 pixels) were captured using
a 40×/0.8 W water-dipping lens (Zeiss Achroplan). Images of
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hippocampal sections from water maze-trained animals were cap-
tured from three deﬁned regions of the hippocampus, i.e., CA1,
CA3, and the apex of the DG. Images taken from acute slice
preparations were captured from the upper (unstimulated) and
lower (TBS-stimulated) blades of the DG. The speciﬁc areas of
the hippocampal neuronal circuit captured were kept consistent
between sections. Three sections from each rat brain and acute
hippocampal slice were used for analysis.
IMAGE ANALYSIS
Image analysis was conducted using EBImage; a package for the R
programming environment (Pau et al., 2010). Analysis of the com-
bined nuclear and surrounding cell soma expression of CX3CL1
ﬂuorescence was calculated for every cell in each image. Brieﬂy,
taking the DG confocal image in Figure S1 as a typical exam-
ple, the red, green and blue channels were ﬁrst separated for
each image and every pixel within the images (1024 × 1024) was
assigned an intensity value between 0 and 1. Using the blue channel
as a nuclear reference, size and ﬂuorescence intensity thresholds
were set in order to select only those pixels likely to represent
Hoechst-labeled nuclei. The nuclei were then ‘dilated’ using mor-
phological kernel expansion. This step allowed the designation of
a soma region surrounding each nucleus. A distance map was then
generated for the image which calculates the distance of each fore-
ground pixel (white) to the nearest background pixel (black). The
watershed segmentation algorithm is then employed which accu-
rately separates clusters of nuclei that are very close together, or
touching, into individual cells. Minimumdistance betweenobjects
and minimum radius criteria are written into the analysis scripts
which further reﬁnes object separation. CX3CL1 immunoﬂuores-
cence is calculated for every cell as the average pixel ﬂuorescence
intensity.
LIVE-CELL CALCIUM IMAGING IN ORGANOTYPIC SLICES AND PRIMARY
HIPPOCAMPAL CULTURES
At 21 days in vitro, organotypic hippocampal cultures were pre-
pared for calcium imaging experiments by transferring inserts
to room-temperature BSS (buffered salt solution) composed of
130mMNaCl, 5.4mMKCl, 1.8mMCaCl2, 2mMMgSO4, 5.5mM
D-glucose, and 20 mM HEPES, pH 7.3. The insert membranes
were cut using a scalpel and individual slices were transferred to
35 mm Petri dishes containing 2 ml of 3 μM ﬂuo-4 AM calcium
indicator (Invitrogen) in BSS and allowed incubate in the dark
for 30 min. Similarly, cover-slips containing mixed neuronal-glial
cultures were individually transferred to standard six-well plates,
containing 3 μM ﬂuo-4 AM in BSS, for 20 min.
Time-series calcium imaging experiments in organotypic slices
were conducted in the CA1 pyramidal cell layer of the hippocam-
pus using an upright LSM V Pascal confocal microscope (Zeiss).
The ﬁeld of view on the 10× water immersion lens was halved
allowing us to monitor calcium responses at a rate of two frames
per second. We measured baseline calcium levels in the ﬁrst 20 s
(i.e. average of 40 frames). After 20 s a solution of glutamate
(30 μM) in BSS was washed onto the slice and ﬁlled the slice
chamber. This glutamate solution remained in the chamber for
105 s. The calcium response of each cell over the 125 s time-course
was calculated using EBImage software. The concentrations of
rCX3CL1 (500pMfor 15min) andpicrotoxin (100μMfor 15min)
used for live-cell calcium imaging experiments in organotypic
slices was the same as those used in acute slice electrophysiology
experiments.
For live-cell calcium imaging experiments in primary mixed
neuron-glial cultures, cells were loaded with 3 μM ﬂuo-4 AM
calcium indicator (Invitrogen) in BSS as above, and were then
transferred to a custom-built imaging chamber containing fresh
BSS. The imaging chamber allowed for wash-in/out of CX3CL1
and glutamate solutions (Pickering et al., 2008). Experiments were
conducted at room temperature using an upright LSM V Pascal
confocal microscope and a 10×/0.3 W Ph1 water-dipping lens so
as to capture several hundred cells per experiment. Time-series
confocal images were captured at frame-rate of 1 Hz. Cells were
pre-treated for 15 min with either 500 pM or 2 nM rCX3CL1.
Baseline calcium levels for every cell were monitored for 20 s prior
to a 30 μM glutamate exposure. This glutamate solution remained
in the chamber for 90 s before being washed out with fresh BSS
solution and frames were captured for a further 40 s. The calcium
response of each cell was calculated every second for 150 s using
EBImage software.
STATISTICAL ANALYSIS
All raw data was imported into GraphPad Prism 6 software
where statistical analyses were performed. Kruskal–Wallis non-
parametric analysis of variance (ANOVA) tests were performed
in conjunction with Dunn’s multiple comparisons post hoc anal-
yses in order to determine statistical signiﬁcance (p < 0.01)
for: (1) CX3CL1 regulation post-spatial learning in rats; (2)
CX3CL1 regulation post-theta burst stimulation in acute hip-
pocampal slices and; (3) glutamate-mediated calcium responses
in primary mixed neuron-glial cell cultures. One-way ANOVA
tests were performed in conjunction with Bonferroni post hoc
analyses in order to determine statistical signiﬁcance (p < 0.05)
for: (1) the reduction in swim-times during water maze train-
ing; and (2) the effect of rCX3CL1 on LTP and paired pulse
ratio. Mann–Whitney U tests were performed in order to
determine statistical signiﬁcance (p < 0.001) for the effects
of rCX3CL1 and picrotoxin on glutamate-mediated calcium
responses in organotypic hippocampal slice cultures. The rela-
tionship between NeuN expression and CX3CL1 expression in the
rat hippocampus was analyzed by Pearson correlation and linear
regression.
RESULTS
CX3CL1 IS HIGHLY EXPRESSED BY NEURONAL CELL TYPES IN THE
ADULT RAT HIPPOCAMPUS
We characterized the expression and distribution of CX3CL1 in
the rat dorsal hippocampus using immunoﬂuorescence. CX3CL1
expressionwas predominately restricted to the glutamatergic pyra-
midal and granule neurons of the hippocampus (Figure 1A).
At higher magniﬁcation, it is clear that CX3CL1 expression
co-localizeswith theneuronalmarkerNeuN inCA1andCA3pyra-
midal neurons (Figures 1B,C; yellowarrowheads), dentate granule
cells (Figure 1D) and presumptive interneurons outside the pri-
mary cell layers in all three hippocampal subﬁelds (Figures 1B–D;
white arrowheads). In all cases, the chemokine appears to be
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FIGURE 1 | Expression of CX3CL1 in the CA1, CA3 and dentate gyrus
(DG) of the rat hippocampus. (A) Basal levels of CX3CL1 expression in the
rat dorsal hippocampus. Green: CX3CL1; Red: propidium iodide-stained
nuclei. Scale bar = 200 μm. (B–D) CA1, CA3 and DG regions of the
hippocampus, respectively, showing CX3CL1 (green), NeuN (red) and Hoechst
(blue) expression.White arrowheads: interneurons; yellow arrowheads: CA
pyramidal neurons. (E) Relationship between CX3CL1 and NeuN expression.
Each dot represents a single cell. Linear regression analyses (red lines)
appear on each plot with corresponding r2 values indicated. Linear regression
p < 0.05 for CA1, CA3 and DG regions of the hippocampus.
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predominantly expressed on the plasma membrane of the cell
soma. We assigned expression intensity values for NeuN and
CX3CL1 to each cell in the image dataset (see Figure S1 for image
analysis method) and then analyzed the relationship between
expression of the mature neuronal marker, NeuN, and CX3CL1
by Pearson correlation in each sub-region of the hippocampus. A
highdegree of correlationwas evident betweenCX3CL1 andNeuN
expression in all three regions of the hippocampus (Figure 1E).
The CA3 region showed the strongest linear regression coefﬁcients
of determination for correlation between CX3CL1 and NeuN
expression (r2 = 0.70, p < 0.05). These data conﬁrm previous
reports that mature NeuN + hippocampal neurons in the adult rat
hippocampus express high levels of CX3CL1 under naïve resting
conditions.
CX3CL1 IS UP-REGULATED 2 h POST-SPATIAL LEARNING IN THE RAT
HIPPOCAMPUS
Rats were trained in a ﬁve-trial water maze session (n = 12 in
total; n = 4 per time point) and the latencies to ﬁnd the platform
were recorded. Latency-to-platform times decreased signiﬁcantly
(one-wayANOVA,p< 0.001) over the ﬁve trials of the training ses-
sion indicating that the animals acquired the task (Figure 2A). We
quantiﬁed CX3CL1 expression in the hippocampus of these rats
using immunoﬂuorescence. Total CX3CL1 expression was very
similar in trained and passive animals 1 h following training in
all hippocampal regions (Figures 2B–D). At the 2 h time-point,
CX3CL1 expression was signiﬁcantly higher in trained animals
compared to passive controls in all three hippocampal regions
analyzed (Kruskal–Wallis ANOVA, Dunn’s multiple comparisons
post hoc test, p < 0.001). At the 3 h time-point in the DG, CX3CL1
expression in trained animals again matched that of passive con-
trols, highlighting the temporal speciﬁcity and transient nature of
the 2 h up-regulation in dentate granule cells of rats that learned
the spatial task. In the CA3, however, there was a signiﬁcant,
training-speciﬁc down-regulation in CX3CL1 expression whereas
levels of CX3CL1 remained elevated in the CA1 region of trained
animals compared to passive control counterparts at the 3 h time-
point (Kruskal–Wallis ANOVA,Dunn’s multiple comparisons post
hoc test, p < 0.01). It should be noted that passive control ani-
mals exhibited an up-regulation in CX3CL1 at the 2 h post-swim
time-point indicating that, in addition to the learning-speciﬁc reg-
ulations described above, this chemokine is also responsive to the
general stressors associated with the paradigm.
CX3CL1 IS UP-REGULATED 2 h POST-THETA BURST
STIMULATION IN DENTATE GRANULE NEURONS
After measuring a learning-speciﬁc up-regulation in CX3CL1 in
pyramidal and dentate granule neurons 2 h post-water maze-
training, we next asked whether CX3CL1 is up-regulated after
LTP-inducing TBS in acute hippocampal slices. TBS was delivered
to the medial perforant path of the lower DG blade, as illustrated
in Figure 3A. LTP was induced and recorded for 2 h, after which
slices were snap-frozen. CX3CL1 expression on stimulated dentate
granule cells was compared to that on neurons located in the upper
unstimulated blade (US) of the DG (Figure 3A). LTP-inducing
TBS resulted in an up-regulation in CX3CL1 expression after 2 h
on the stimulated DG blade compared to the upper unstimulated
DG blade (Figure 3B). No such difference between upper and
lower blades was observed in time-matched control slices which
received no stimulation.
EFFECTS OF CX3CL1 ON LTP IN THE DENTATE GYRUS DEPENDS ON
INHIBITORY TONE AND GABAA RECEPTORS
We investigated a possible functional role for CX3CL1 up-
regulation in modulating synaptic transmission during memory-
associated synaptic plasticity. Previous studies have shown that
CX3CL1 inhibits LTP and mimics long-term depression (LTD)
at the CA3–CA1 synapses in acute hippocampal slices (Bertollini
et al., 2006; Ragozzino et al., 2006; Maggi et al., 2009). Given
that we observed memory-associated increases in CX3CL1 lev-
els in CA1, CA3, and DG regions of the hippocampus fol-
lowing spatial learning, we next asked what effect CX3CL1
exerts on LTP in the dentate granule cell synaptic ﬁeld. Pre-
treatment with CX3CL1 (500 pM) signiﬁcantly reduced induc-
tion and completely prevented maintenance of LTP in the DG
(Figure 4A).
Consistentwithpreviousworkonpyramidal hippocampal neu-
rons (Ragozzino et al., 2006), the paired-pulse ratio of DG neuron
responses evoked by two successive stimuli (50 ms apart) was
unaffected by CX3CL1 treatment either at baseline or following
TBS (Figure 4B). While not ruling out a presynaptic contribution,
these data support a post-synaptic action for CX3CL1-mediated
inhibition of fEPSP amplitude in the DG following TBS.
Recent evidence has shown that CX3CL1 reduces the activity
of serotonergic neurons in the Raphe nucleus through enhanced
GABAA receptor-mediated inhibition (Heinisch and Kirby, 2009).
We next investigated if CX3CL1-mediated control of glutamater-
gic neuroplasticity in the hippocampal DG requires GABAergic
inhibitory transmission. LTP was induced in the presence of
GABAA receptor/chloride channel blocker picrotoxin (100 μM)
using the same TBS protocol as in Figure 4A. As expected,
the degree of potentiation of fEPSP amplitude was substantially
greater in the presence of GABAA receptor blockade (117 ± 5%
versus 200 ± 3% of baseline average in ﬁrst 10 min post-TBS in
the absence and presence of picrotoxin, respectively; Figures 4A,C;
Arima-Yoshida et al., 2011). Interestingly, CX3CL1 did not prevent
LTP in the presence of picrotoxin (Figure 4C). In fact, when picro-
toxin was present, themagnitude of LTPwas enhanced byCX3CL1
during the initial 20 min following the TBS (p < 0.05). CX3CL1
again had no effect on paired-pulse depression in the presence
of picrotoxin (Figure 4D) suggesting a post-synaptic action for
CX3CL1-mediated short-term enhancement of fEPSP amplitude
following TBS.
EFFECTS OF CX3CL1 ON GLUTAMATE-INDUCED CALCIUM RESPONSES
IN THE HIPPOCAMPUS REQUIRES GABAA RECEPTOR ACTIVATION
Long-term potentiation of excitatory synaptic transmission in the
hippocampus is heavily dependent on post-synaptic intracellular
calcium rise (Bliss and Collingridge, 1993). We next assessed if
CX3CL1 exerts differential effects on glutamate-induced intra-
cellular calcium rise in the presence and absence of GABAA
receptor blockade. Live-cell calcium imaging was performed in
organotypic hippocampal slice cultures pre-treated with CX3CL1
(500 pM) and/or picrotoxin (100 μM) for 15 min. Slices were
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FIGURE 2 |Temporal changes in CX3CL1 expression in the rat
hippocampus post-spatial learning measured by immunofluorescence.
(A) Graph shows the average latency-to-platform times for rats trained in
a single session (ﬁve trials) of the water maze task (n = 12). (B–D) Box
plots represent the distributions of ﬂuorescence intensity values for
CX3CL1 protein expression in CA1, CA3, and DG cells at 1, 2 and 3 h
post-water maze training, compared to passive control animals. Changes
in CX3CL1 expression were analyzed using Kruskal–Wallis ANOVA and
Dunn’s multiple comparisons post hoc tests; ∗p < 0.01. There were four
rats per time-point and three hippocampal sections analyzed per animal.
The numbers of cells analyzed per hippocampal region were as follows:
CA1: 1116–1201 cells; CA3: 1090–1247 cells; DG: 2888–3455 cells. The
numbers of cells analyzed per time-point were: 1 h: 11,526 cells; 2 h:
10,355 cells; 3 h: 10,867 cells.
then exposed to glutamate (30 μM) and intracellular calcium
was monitored for 1 min 45 s in the CA1 pyramidal cell
layer of the hippocampus. Pre-treatment with CX3CL1 prior
to glutamate application resulted in an attenuated intracellu-
lar calcium rise in cells in the CA1 region of organotypic slice
cultures (Figure 4E). While the peak amplitude of the cal-
cium response in CX3CL1-treated slices was not different than
in controls (Figure S2A), the total calcium entry in the 60 s
post-glutamate exposure was reduced, as calculated by the area
under the curve (AUC) in Figure 4E. In contrast, in the pres-
ence of GABAA receptor/chloride channel blockade, CX3CL1
enhanced glutamate-induced calcium inﬂux as measured by AUC
(Figure 4F) or peak intracellular calcium (Figure S2B). These
ﬁndings are consistent with the opposing actions of CX3CL1 on
LTP studies in the presence and absence of picrotoxin. They sug-
gest that neuronal responses to CX3CL1 can vary depending on
the balance between excitation and inhibition in the hippocam-
pal network. Therefore, during periods of enhanced excitatory
activity in the hippocampus, CX3CL1 may act as a neuropro-
tective dampener of excessive glutamatergic neurotransmission
and this action appears to be dependent on GABA-mediated
inhibition.
CX3CL1 INHIBITS GLUTAMATE-INDUCED CALCIUM DYNAMICS IN
BOTH NEURONS AND GLIAL CELL TYPES
In order to assess if physiological concentrations of CX3CL1 exert
equivalent effects on glutamate-induced calcium responses in both
neurons and non-neuronal cell populations, we used hippocampal
mixed cell culture preparation. Primary hippocampal cells were
pre-treated with CX3CL1 (500 pM or 2 nM) for 15 min prior
to glutamate (30 μM) challenge. Importantly, we have shown
previously that using this mixed hippocampal cell culture prepa-
ration, we can discriminate between neurons and non-neuronal
cells based on the shapes of their respective glutamate-mediated
calcium response curves (Pickering et al., 2008). This allowed us
to simultaneously evaluate the effects of different concentrations
of CX3CL1 on intracellular calcium dynamics in neurons and
non-neuronal cells following glutamate exposure (Figures 5A–C).
This method of distinguishing between neurons and non-neuron
cell types was shown to be as accurate as traditional methods of
immunocytochemistry staining for neuronal and glial cell mark-
ers (NeuN and GFAP, respectively; Pickering et al., 2008). Neurons
were identiﬁed by their substantial and prolonged increase of
intracellular calcium following glutamate administration while
non-neurons exhibited a sharp rise and fall back to plateaux
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FIGURE 3 | CX3CL1 expression increases 2 h following theta-burst
stimulation-induced LTP in the DG of acute hippocampal slices.
(A) Schematic diagram illustrating the position of stimulating and recording
electrodes in hippocampal LTP experiments. Electrodes were always
placed in the medial molecular layer of the lower blade of the DG
approximately 100–200 μm apart. US, unstimulated DG blade; TBS,
theta-burst stimulated blade. (B) Box plots showing the distribution of
CX3CL1 ﬂuorescence intensities in the upper and lower blades of the DG in
stimulated slices and time-matched control slices. Asterisk indicates
signiﬁcant difference from the US blade (Kruskal–Wallis ANOVA and Dunn’s
multiple comparisons post hoc tests; p < 0.001).
(Figures 5D,E, respectively). In non-neuronal cells, both low
(500 pM) and higher (2 nM) physiologically relevant concentra-
tions of CX3CL1 attenuated glutamate-induced calcium inﬂux,
in a dose-dependent manner (Kruskal–Wallis ANOVA, Dunn’s
multiple comparisons post hoc test, p < 0.05; Figures 5E,G). In
neurons, however, the lower concentration of CX3CL1 (500 pM)
had little or no effect on glutamate-induced calcium inﬂux
(Figures 5D,F; and Figure S2C). Pre-treatment of hippocampal
cultures with a higher concentration (2 nM) of CX3CL1 caused a
substantial attenuation of glutamate-mediated calcium responses
in neurons (Kruskal–Wallis ANOVA, Dunn’s multiple compar-
isons post hoc test, p < 0.001; Figures 5D,F), in addition to
causing further dose-dependent attenuations in calcium inﬂux in
non-neuronal cell types (Figures 5E,G; and Figure S2D). The dif-
ferential responses of CX3CL1 on neurons and non-neurons at the
lower concentration (500 pM) may relate to variations in absolute
levels of CX3CR1 receptor expression on distinct cell populations
in the hippocampus.
DISCUSSION
CX3CL1 is among an increasing number of cytokines and
chemokines implicated in both normal functions and patho-
physiological conditions of the brain (White and Greaves, 2012;
Mattison et al., 2013; Sheridan and Murphy, 2013; Wu et al., 2013;
Briones et al., 2014). In the present study, we identiﬁed a tran-
sient up-regulation of CX3CL1 production in the hippocampus
2 h following spatial learning or induction of LTP. Importantly,
these up-regulations were speciﬁc to either the memory encoding
process or the TBS since the up-regulations measured were com-
pared directly to swim-matched passive controls or unstimulated
dentate granule cells, respectively. In addition, we did observe
a 2 h up-regulation in CX3CL1 in the passive control group of
animals, indicating that this chemokine may also be responsive
to stress and anxiogenic environmental conditions. However, the
signiﬁcant training-speciﬁc up-regulations in CX3CL1, over and
above those measured in passive control animals at the 2 h time-
point, implicate CX3CL1 in memory-related synaptic plasticity
in the hippocampus. The enhanced glutamate neurotransmission
and resultant increase in hippocampal neuronal activity asso-
ciated with both spatial memory formation and LTP are the
most likely drivers of the production of CX3CL1 in our stud-
ies. CX3CL1 has been reportedly up-regulated in several settings
of augmented glutamatergic transmission where the chemokine is
clearly protective against excitotoxic cell death (Tong et al., 2000;
Tarozzo et al., 2002; Limatola et al., 2005; Cipriani et al., 2011;
Briones et al., 2014). Moreover, both CX3CL1 and its receptor,
CX3CR1, have been shown to be up-regulated in hippocampal
neurons after pilocarpine-induced status epilepticus (Yeo et al.,
2011), a condition characterized by excessive glutamatergic exci-
tation. Interestingly, 3 h post-learning, we observed opposing
regulations in CX3CL1 in the CA1 and CA3 pyramidal cell lay-
ers. This may relate to distinct plasticity mechanisms and/or
distinct functions of these hippocampal subregions during spa-
tial memory tasks (Hunsaker and Kesner, 2008; Rolls, 2010).
Overall, the abundance and expression pattern of CX3CL1 make
the chemokine ideally suited for sensing hippocampal glutamate
tone. Our data supports a possible role for CX3CL1 in homeo-
static mechanisms of synaptic scaling during memory-associated
synaptic plasticity.
Previous studies have reported that CX3CL1 inhibits LTP and
induces LTD-like effects in the CA1 region of the hippocam-
pus (Bertollini et al., 2006; Ragozzino et al., 2006; Maggi et al.,
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FIGURE 4 | Differential effects of CX3CL1 on long-term potentiation (LTP)
in the DG and glutamate-induced intracellular calcium rise in the CA1, in
the presence and absence of GABAA/chloride receptor blockade. (A)The
effect of the chemokine domain of CX3CL1 on LTP in acute hippocampal
slices as measured by augmented ﬁeld EPSP magnitude in the DG following
theta-burst stimulation (TBS: 8 × 8 × 200 Hz). CX3CL1 inhibited dentate LTP
in both the early and late phases post-TBS (i.e., 20–40 min and 40–80 min,
respectively; one-way ANOVA; p < 0.05, indicated by an asterisk; n = 8 slices
per group). CX3CL1 (500 pM) was present for the duration of the time period
shown. (B) Shows the paired-pulse ratio between the ﬁrst and second
stimulations (50 ms interval) in the LTP experiment inA. (C) Shows the effect
of CX3CL1 on dentate LTP in acute hippocampal slices as measured by
augmented ﬁeld EPSP magnitude followingTBS in the presence of picrotoxin
(100 μM). CX3CL1 (500 pM) and picrotoxin were present for the duration of
the time period shown. CX3CL1 enhanced early LTP (one-way ANOVA;
p < 0.05, indicated by an asterisk; n = 8 slices per group) while having no
effect on late LTP. (D) Shows the paired-pulse ratio between the ﬁrst and
second stimulations (50 ms interval) in the LTP experiment in C. (E) Shows
the effect of CX3CL1 on glutamate-induced calcium inﬂux in the CA1 region
of organotypic hippocampal slices cultured for 21 DIV. Pre-treatment of slice
cultures with CX3CL1 (500 pM) for 15 min prior to glutamate exposure
reduced calcium inﬂux in the CA1 region (Mann–Whitney U test; p < 0.001).
Box plot inset shows the area under the curve (AUC) for the whole
experimental time-course. CX3CL1 (500 pM) was present for the duration of
the time period shown. (F)The effect of CX3CL1 on glutamate-induced
calcium inﬂux in the CA1 region of organotypic hippocampal slices in the
presence of picrotoxin. Pre-treatment of slice cultures with CX3CL1 (500 pM)
and picrotoxin (100 μM) versus picrotoxin alone (control) for 15 min prior to
glutamate exposure enhanced calcium inﬂux in the CA1 region
(Mann–Whitney U test; p < 0.001). Box plot inset shows the area under the
curve (AUC) for the whole experimental time-course. CX3CL1 (500 pM) and/or
picrotoxin (100 μM) were present for the duration of the time period shown.
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FIGURE 5 | Effect of CX3CL1 on glutamate-induced calcium dynamics in
neurons and glia. (A–C) Representative images of intracellular calcium
[Ca2+]i levels in mixed neuron-glial primary hippocampal cultures before and
after 30 μM glutamate exposure. Control cells (A) were untreated prior to
glutamate exposure. Treated cells were exposed to either (B) 500 pM or (C)
2 nM CX3CL1 for 15 min. Scale bar = 200 μm. (D,E) Shows the time-course
of the [Ca2+]i response to glutamate in neurons (D) and non-neuronal cells
(E). Cells were treated for 15 min with either 500 pM (blue circles) or 2 nM
(green circles) CX3CL1 for 15 min prior to 30 μM glutamate exposure.
Untreated control time-course is represented by black circles. Relative
changes in [Ca2+]i were calculated for each cell at each time point as f /f 0,
where f is the [Ca2+]i ﬂuorescence in each frame and f 0 is the average
baseline ﬂuorescence per cell, calculated 20 s prior to glutamate addition.
Primary hippocampal cell cultures were divided into neurons (138, 171, and
101 cells for control, 500 pM and 2 nM CX3CL1-treated cells, respectively)
and non-neuronal (432, 726, and 604 cells for control, 500 pM and 2 nM
CX3CL1-treated cells, respectively) cell populations based on their [Ca2+]i
response to 30 μM glutamate (Pickering et al., 2008). (F,G) Quantiﬁcation of
the calcium imaging time-courses in D and E. 500 pM CX3CL1 attenuates
glutamate-induced [Ca2+]i increases in non-neuronal cell types
(Kruskal–Wallis ANOVA and Dunn’s multiple comparisons post hoc tests;
∗p < 0.05), but has no signiﬁcant effect on [Ca2+]i response in neurons.
Pre-treatment of hippocampal cell cultures for 15 min with 2 nM CX3CL1,
however, signiﬁcantly attenuates glutamate-induced [Ca2+]i inﬂux in both
non-neuronal cells and in neurons (Kruskal–Wallis ANOVA and Dunn’s multiple
comparisons post hoc tests; ∗p < 0.001). The results represent combined
data from ﬁve to six individual cover-slips per treatment group and from two
separate cell culturing days.
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2009). We found a matching inhibitory action of CX3CL1 on
LTP in the DG. These observations are in good agreement with
CX3CL1-mediated inhibition of glutamatergic synaptic activity of
hippocampal neurons (Ragozzino et al., 2006). CX3CL1-mediated
regulation of glutamate transmission has been shown to be due
to its post-synaptic effects on neurons and involves the dephos-
phorylation of the GluR1 AMPA receptor subunit on serine 845,
a mechanism reminiscent of LTD (Ragozzino et al., 2006). LTD
can play vital roles in the context of memory-associated synaptic
plasticity including synaptic scaling and enhanced signal-to-noise
ratio mechanisms.
The GABAA receptor/chloride channel blocker, picrotoxin,
used in the current studies would decrease GABAergic inhibitory
transmission promoting depolarization in some cells with cor-
responding increases in intracellular calcium (Antonucci et al.,
2012). Thus, the current work suggests GABAA receptor/chloride
channel activity within the hippocampal neuronal network must
be intact for CX3CL1 to attenuate glutamatergic neurotrans-
mission or LTP. This situation is remarkably similar to that
described for CX3CL1 inhibition of serotonergic neurons of the
Raphe nucleus (Heinisch and Kirby, 2009). While this effect
may relate to basal inhibitory tone, CX3CL1 could actually be
enhancing GABAA receptor function. For example, CX3CL1
enhances phosphorylation and activation of Akt in neurons and
this serine/threonine kinase has been associated with phosphory-
lation of the GABAA beta2 receptor subunit, a modiﬁcation that
enhances activity of the receptor (Meucci et al., 2000; Wang et al.,
2003). Moreover, several signaling systems can enhance GABA-
mediated inhibition through promotion of rapid insertion of
GABAA receptors into the post-synaptic plasma membrane (Wan
et al., 1997; Nusser et al., 1998; Mizoguchi et al., 2003; Jovanovic
et al., 2004).
When discussing potential mechanisms by which CX3CL1
inﬂuencesneuronswemust tomindful of the inconsistencies in the
literature with regard to the expression of the CX3CR1 receptor
by neurons (Meucci et al., 1998, 2000; Maciejewski-Lenoir et al.,
1999; Jung et al., 2000; Hatori et al., 2002; Hughes et al., 2002;
Tarozzo et al., 2003; Deiva et al., 2004; Verge et al., 2004; Limatola
et al., 2005; Cardona et al., 2006; Zhuang et al., 2007; Heinisch
and Kirby, 2009; Ruchaya et al., 2012, 2014). The consensus
from work with the CX3CR1−/−-GFP knock-in mouse (Car-
dona et al., 2006) suggests that CX3CR1 expression is restricted
to microglial cells in the CNS under naïve conditions in vivo.
Studies of CX3CR1 expression in rats, however, have found evi-
dence of receptor expression on neuronal cell types in various
brain regions (Heinisch and Kirby, 2009; Ruchaya et al., 2012,
2014). Here, we report rapid modulatory effects of CX3CL1 on
neuronal events in hippocampal tissue. Our data does not con-
clusively support a direct action of CX3CL1 on neurons and we
cannot discount the possibility that the effects we see on LTP and
calcium inﬂux in neuronal cell types happen as a consequence of
CX3CL1-mediated activation of CX3CR1 solely on microglial cell
types. If this is true, however, the ability of microglia to rapidly
regulate multiple hippocampal memory-associated synaptic plas-
ticity processes may be much more extensive than traditionally
thought. The evidence from rats that CX3CR1 is expressed on
hippocampal neuron allows the possibility that, as is the case
for CX3CL1-mediated regulation of serotonergic neurons of the
dorsal Raphe, glutamatergic neuron-derived CX3CL1 may act
in an autocrine/paracrine fashion in the hippocampus during
periods of synaptic plasticity to regulate glutamate-mediated
neurotransmission tone.
While previous studies have shown that CX3CL1 causes an
increase in intracellular calcium in neurons and other cell types
(Oh et al., 2002; Deiva et al., 2004; Ragozzino et al., 2006) this
effect of CX3CL1 becomes apparent at concentrations of 25 nM
and higher (Oh et al., 2002; Deiva et al., 2004), well above the
levels we investigated here and we observed no such increase in
intracellular calcium. At a concentration of 2 nM, in both neurons
and non-neurons, CX3CL1 pre-incubation suppressed glutamate-
mediated rises in intracellular calcium levels. These data are in
good agreement with previous ﬁndings of a protective effect of
inﬂammatory levels of CX3CL1 against glutamate excitotoxicity
and glutamate NMDA receptor activation, in particular (Meucci
et al., 1998; Deiva et al., 2004; Limatola et al., 2005), although,
unlike the current work, the latter effect was linked to increased
intracellular calcium (Ragozzino et al., 2006). Calcium oscillations
in both neuronal and non-neuronal cells are important for cellular
growth, migration and synaptic structural reﬁnement (Katz and
Shatz, 1996; Komuro and Rakic, 1998; Spitzer et al., 2000). Thus,
the dampening of such signaling by CX3CL1 is suggestive of a role
in stability of network connectivity and activity. Overall, the cur-
rent data along with information in the published literature reveal
that a role for CX3CL1 in control of glutamate-mediated excita-
tory neurotransmission during excitotoxic events can be extended
to situations of synaptic plasticity required for normal functions
such as memory formation.
An increasing number of chemokines exhibit extensive reg-
ulation across a range of situations where neuronal plasticity
is involved; including memory-associated functional plasticity,
protective plasticity in the setting of ischemia and maladaptive
plasticity such as that underpinning neuropathic pain (Adler
et al., 2006; Rostene et al., 2007; McAfoose and Baune, 2009; Old
and Malcangio, 2012). Speciﬁcally, the role for CX3CL1 in con-
trol of hippocampus and Raphe activity suggests that infection-,
inﬂammation-, and/or chronic disease-associated increases in the
chemokine could contribute to reduced hippocampal and Raphe
output, alterations that could, in turn, precipitate depressed mood
and heightened anxiety among other disorders of brain func-
tion (Meltzer, 1990; Bast, 2011; Small et al., 2011). The extensive
expression of CX3CL1 on neurons in the adult hippocampus
and CX3CL1 up-regulation post-spatial learning supports a direct
role for CX3CL1 in memory-associated synaptic plasticity. To
better understand the role of CX3CL1 up-regulation follow-
ing learning it will be important to assess the consequences of
blocking such chemokine signaling on learning and memory
function.
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Figure S1 | Image analysis automation using EBImage software. (A) 40×
magniﬁcation of the apex of the hippocampal dentate gyrus. Green: CX3CL1;
Red: NeuN and Blue: Hoechst. Scale bar = 50 μm. (B) Hoechst channel alone.
Stains cell nuclei. (C) NeuN channel alone. Labels neuronal cell bodies. (D)
CX3CL1 channel alone. Labels CX3CL1 protein on dentate granule cells. (E)
The blue ﬂuorescence intensity was thresholded in order to select only
Hoechst-stained nuclei (white). (F) Using a morphological kernel expansion
algorithm, nuclei were dilated to select a cell soma region surrounding each
nucleus. (G) A distance map was generated which calculates the distance each
foreground (white) pixel is from the nearest background (black) pixel. (H)The
watershed segmentation algorithm was then employed in order to separate all
cell bodies from one another. The varying shades of gray in the image denote
separated cells.
Figure S2 | Effect of CX3CL1 on the peak glutamate-induced calcium
response in organotypic slice cultures and mixed hippocampal cell
cultures. (A) Shows the effect of CX3CL1 on glutamate-induced calcium inﬂux
in the CA1 region of organotypic hippocampal slices cultured for 21 DIV.
Pre-treatment of slice cultures with CX3CL1 (500 pM) for 15 min prior to
glutamate (30 μM) exposure had no effect on the peak Ca2+ ﬂuorescence
intensity achieved by each cell (Mann–Whitney U test; p < 0.001). (B) Shows
the effect of CX3CL1 on glutamate-induced calcium inﬂux in the CA1 region of
organotypic hippocampal slices in the presence of picrotoxin. Pre-treatment of
slice cultures with CX3CL1 (500 pM) and picrotoxin (100 μM) versus picrotoxin
alone (control) for 15 min prior to glutamate (30 μM) exposure enhanced the
peak Ca2+ ﬂuorescence intensity achieved by each cell (Mann–Whitney U test;
p < 0.001). (C) Shows the effect of CX3CL1 (500 pM and 2 nM) on
glutamate-induced calcium inﬂux in neuronal cell types within mixed
hippocampal cell cultures. Pre-treatment of primary hippocampal cell cultures
with the lower dose of CX3CL1 (500 pM) for 15 min prior to glutamate (30 μM)
exposure had no effect on the peak Ca2+ ﬂuorescence intensity achieved by
each neuronal cell (Kruskal–Wallis ANOVA and Dunn’s multiple comparisons
post hoc tests; p < 0.001). The higher dose of CX3CL1 (2 nM), however,
attenuated the peak Ca2+ ﬂuorescence intensity achieved by neurons in
response to glutamate application. (D) Shows the effect of CX3CL1 (500 pM
and 2 nM) on glutamate-induced calcium inﬂux in non-neuronal cell types within
mixed hippocampal cell cultures. Pre-treatment of primary hippocampal cell
cultures with the lower dose of CX3CL1 (500 pM) for 15 min prior to glutamate
(30 μM) exposure had no effect on the peak Ca2+ ﬂuorescence intensity
achieved by each non-neuronal cell (Kruskal–Wallis ANOVA and Dunn’s multiple
comparisons post hoc tests; p < 0.001). The higher dose of CX3CL1 (2 nM),
however, attenuated the peak Ca2+ ﬂuorescence intensity achieved by each
non-neuronal cell in response to glutamate application.
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